1,2-Dilauroyl-sn-glycero-3-phosphocholine: Designed for Today’s Lipid Science

Pushing Forward with True Phospholipids

We’ve spent years optimizing the production of 1,2-Dilauroyl-sn-glycero-3-phosphocholine, often abbreviated as DLPC. This phospholipid draws from the heart of traditional glycerophosphocholine chemistry, but with a specific feature set that meets the demands of both cutting-edge laboratories and applied industries. Our facility produces DLPC using refined chemical synthesis techniques, ensuring purity and batch consistency, two metrics our teams monitor closely. Many users recognize DLPC by its CAS number 4235-95-4 or its detailed IUPAC name. But among those developing liposomes, reconstituting membrane proteins, or diving deep into membrane biophysics, the real appreciation comes from how it behaves — and how reliably it behaves, batch after batch.

Let’s talk about why this molecule makes a difference. DLPC features two dodecanoyl (lauric acid) chains bound to the sn-1 and sn-2 positions of glycerol, with a phosphocholine headgroup at sn-3. Structurally, this puts DLPC in the phosphatidylcholine (PC) class, but the relatively shorter 12-carbon chains (compared to more common 16- and 18-carbon PC lipids) push its physical properties in a direction that fits special applications. That shorter tail length means a transition temperature well below room temperature, which gives researchers a handle on creating more fluid, less ordered lipid membranes in vitro. The practical upshot? DLPC supports those protocols where a highly fluid bilayer proves essential — such as studies of membrane protein flexibility, or quick drug diffusion in model systems.

Why Purity Matters in Real Work

Contamination, even at low levels, throws off biophysical measurements, triggers unpredictable vesicle formation, or introduces variables into protein-lipid interaction assays. We take product purity seriously, running every DLPC lot through modern chromatographic and NMR-based methods. Our control chemists cross-check each step, from initial raw materials to the final packaged phospholipid powder. It makes a noticeable difference, especially for electrophysiology or high-resolution microscopy labs. We have worked with academic labs, pharmaceutical formulation groups, and industrial partners, all of whom stress the need for dependable starting material.

Users want to know the source and process details, especially those in regulated environments. Each gram of DLPC leaves our site only after passing multiple identity and purity checks. Most batches run better than 99 percent pure by HPLC. The choline headgroup’s fidelity and absence of oxidized acyl chains are the main things we test. We avoid animal-derived reagents and solvents that cause trouble downstream. We’ve seen projects get delayed elsewhere by contaminants that lurk in supposedly high-purity lipid bottles. Listening to customers working on protein reconstitution or sensitive drug delivery programs, we set our quality benchmarks to avoid those snags.

A Closer Look at Lab Use and Applications

Research and applied science teams use DLPC most frequently in liposome preparation. The significance of chain length stands out especially here. Short, saturated chains such as those of lauric acid prevent the tight packing seen with longer chains like palmitoyl or stearoyl counterparts. Liposomes based on DLPC dissolve into more fluid, dynamic bilayers. In our direct shipping observations, we see it move from our silos to academic investigator benches and industrial R&D environments in convenient vials, without loss in performance. Labs routinely hydrate it in buffered solutions, often at temperatures from 10°C to 37°C, watching for vesicle size and uniformity that predict downstream results.

Membrane mimetics and protein studies both draw on the properties of DLPC. In single-channel reconstitution, patch-clamp, or planar lipid bilayer setups, it sets a baseline of low gel-liquid crystalline transition temperature (around -1°C to -2°C). This characteristic keeps membrane models mobile and soft even at cold temperatures, something that longer-chained PCs simply don’t allow. Scientists studying channels, pumps, and membrane-active peptides count on this trait for reproducibility and fidelity to physiological-like conditions, without unwanted domain formation due to chain mismatch or slow diffusion.

Outside the biophysical and biochemistry spaces, professionals formulate DLPC-based vesicles with entrapped drugs, investigating release properties and bilayer fusion behaviors. DLPC’s reduced transition temperature becomes a design tool, enabling rapid release profiles or increased permeability, depending on project needs. Because of its high baseline purity, users encounter fewer headaches during scale-up for preclinical development, when tiny impurities in similar products show up as unexpected peaks in forced-degradation profiles or stability tests.

DLPC Versus the Other PCS — A Hands-On Comparison

In our work with pharmaceutical and academic clients, we constantly get asked: Why pick DLPC over classic PCs like DPPC (1,2-dipalmitoyl-sn-glycero-3-phosphocholine), DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine), or POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine)? The answer rests on the facts of membrane structure. DLPC’s C12:0 saturated acyl chains create a thinner bilayer, roughly 45 angstroms, as measured by X-ray diffraction. DPPC or DSPC, with their 16- or 18-carbon chains, build thicker and more rigid structures, often forming gels or domains at room temperature. DOPC and POPC, sporting unsaturated tails, bring fluidity but also increase susceptibility to peroxidation and chemical instability. DLPC, with two short, saturated chains, sidesteps both rigidity and oxidation worries.

The benefits of this become obvious in real work. We’ve watched teams using DPPC stymied by the lack of bilayer flexibility in their planar patches at 20°C, while those using DLPC breeze through membrane fusion experiments or quickly achieve vesicle mixing. On the other side, DOPC delivers great fluidity but can’t match the chemical robustness of saturated chains for certain drug delivery models. DLPC bridges these needs — maintaining flexibility and handling stress from heat, freeze-thaw cycles, or repeated solubilization steps. Blending DLPC with cholesterol or mixing in other minor lipids fine-tunes properties without having to wrangle excessive oxidation or aggregation.

Manufacturing Considerations and Upstream Value

We synthesize DLPC using high-integrity routes, starting from pure lauric acid and controlled glycerophosphocholine intermediates. Our specialists watch each step, paying attention to temperature, pH, and solvent purity. Direct oversight makes a difference, especially in phosphatidylcholine chemistry, where side-chain migration or partial acylation can wreck a batch. By scaling up using stainless steel reactors and scrupulously maintaining anhydrous conditions, we produce volume supplies without compromising expected quality. Automated column systems, controlled evaporation, and immediate vacuum storage lock in product freshness and stop hydrolysis.

We've responded to changing legal requirements and scientific demands by keeping all records and logs accessible during audits. Our labs support both gram-scale academic purchases and multi-kilogram shipments for industry trials. Batch integrity checks against published reference spectra keep users confident, as we do not blend lots or stretch shelf life by “refreshing” outdated inventory. We label product with clear lot numbers and analysis certificates so users trace every shipment back to its origin.

Some groups opt for DLPC for temperature-sensitive nanoparticle encapsulation, where stable, rapid phase changes at low or moderate temperatures matter. Our experience shows that poorly characterized or aged DLPC, especially that acquired through multiple resellers, often shows altered phase behavior, delayed vesicle formation, or loss of reproducibility. Direct purchase from primary manufacturing retains chain-length fidelity and avoids micro-contamination from reused packaging or uncontrolled supply chains. We field questions from teams working with newly engineered membrane proteins who report clear impacts on their assay results simply from subtle purity differences. These interactions push us to refine controls and tune process steps even further.

Safety, Handling, and Storage from the Manufacturer’s View

DLPC looks like a white to off-white powder at room temperature. Out in the field, users often dissolve it in ethanol, chloroform, or a buffer mix before hydration. Because of its saturated chains and phosphocholine group, it holds up during repeated freeze-thaw cycles, and it resists spontaneous oxidation and hydrolysis better than unsaturated analogs. Still, as a manufacturer, we instruct users to work with minimal moisture and to reseal containers after use. Full anhydrous tight packaging with inert gas blanketing, especially for bulk shipments, maintains stability during transit.

From a chemical standpoint, DLPC does not require extreme storage conditions — refrigeration suffices for multi-year shelf life. We’ve run occasional accelerated stability tests illustrating negligible degradation, even in less-than-ideal field labs. This resilience sets it apart from unsaturated PCs, which demand stricter cold-chain logistics and extra antioxidants to deter spoilage. Laboratories formulating vaccine adjuvants or rapid-reconstitution drug carriers report fewer surprises tied to oxidation artifacts or low-level breakdown products with DLPC as their matrix.

Building Reliable Relationships with Users

It’s not just about making a molecule on paper; it’s about turning chemical processes into reliable supply and actionable data. We answer to teams who need transparency on all parts of the process. Whenever researchers find an anomaly in their experiment, our people step in with archived batch data and technical support. By maintaining direct manufacturing oversight from raw material sourcing through final product testing, we avoid the ambiguity that slips in with multi-layer supply chains. Our open-door policy with both technical and non-technical users means we hear about project delays, odd analytic peaks, and field-specific concerns.

User feedback guides our next process changes. After a project involving large-scale liposome manufacture for a biotech client, we revisited solvent wash steps and improved product packing to meet stricter trace metal limits. When a new protein platform came online, we checked compatibility by spiking our DLPC into test runs, looking for any hint of interference. It’s through these cycles that our DLPC evolves, not just as a chemical, but as part of workflow, from bench science up to product translation. We work closely with direct users, not just distributors. Over the years, we’ve found that open conversation, combined with meticulous in-house process monitoring, leads to better and more consistent results for everyone.

Supporting Innovation in Lipid Science

Foundational lipids like DLPC may seem simple, but process nuances and end-use realities make for complicated chemistry. Our manufacturing environment shapes every step — from raw material purity to the techniques used for acylating the glycerol backbone. Avoiding excess heat, unnecessary agitation, or prolonged exposure to open air helps guarantee the texture and properties our customers count on. Technical specs alone don’t cover all the angles; insight into application drives our ongoing development. We have grown alongside scientists who built new vaccine delivery systems on the back of synthetic phospholipids, and with membrane biophysicists reconstructing artificial cells for the first time. DLPC’s consistent performance and tunable utility have provided the foundation for hundreds of these projects.

We keep pushing on, refining our DLPC as the science moves. Years ago, field users started asking for custom blends of DLPC with select co-lipids, or with antifungal agents or site-specific fluorophores covalently attached to the headgroup. Our process engineers tuned synthetic routes to enable these modifications without harming basic purity. Down the line, we worked with vaccine engineers fine-tuning nanocarrier platforms. Because we run both small-batch and industrial-scale reactors, our teams could answer these requests without major delays or steep cost jumps. We develop every new protocol in close contact with external trial users, so tweaks or troubleshooting remain in sync with the scientific push forward.

Combining Practical Experience with Scientific Rigor

DLPC isn’t just another chill-room staple. Its shorter chain length shifts the phase landscape, carving out unique applications. The seasoned researchers, postdocs, and technologists who call or email us for advice rarely want generic talking points, so we keep our advice grounded in what we see in our QC logs and the test data from varied customer projects. We’ve spent hours on the line discussing hydration protocols, solvent ratios, and film-drying techniques — because a bit of handling finesse can make the difference between sharp, clear data and wasted effort. The practical knowledge built through years of production reflects in the real-world outcomes our users experience.

Rigorous attention to detail keeps every DLPC batch within spec. The challenge of making complex lipids at scale, without losing the accuracy of small-batch runs, forms the core of our everyday work. While synthesizing kilogram lots, we simultaneously prepare analytical-grade samples for those needing maximum traceability. This dual approach sets us apart from less invested resellers or those repacking from anonymous overseas suppliers. Our deep-in-the-trenches knowledge means we can guide users through sample prep, troubleshooting, and even unexpected analytic headaches. This circle of practice and feedback sharpens every subsequent batch we put out.

Championing Responsible Chemical Stewardship

Sustainability and responsible chemistry can’t just be buzzwords for us. The solvents, reagents, and waste streams generated during DLPC synthesis present genuine environmental and safety challenges. We run recovery and neutralization streams in parallel with production. Staff handle acyl chlorides, phosphorus-based moieties, and organic solvents within closed-loop setups. Documentation stays current, and periodic in-house audits push ongoing improvement. Regular investment in waste minimization and process energy efficiency help us match evolving regulations and user expectations. Our manufacturing choices don’t just reduce environmental impact — they translate to more reliable and predictable quality for customers working in drug development or vaccine research, where process clarity is a must.

Industry partners want evidence, not just claims, so we share environmental management protocols during audits and upon request. As customers push toward greener chemistry and lower contaminant profiles, we’ve phased out a range of legacy solvents, ramped up recycling, and trained teams on cross-audit processes. For DLPC, this translates as cleaner, safer production without the inevitable risk of introducing “invisible” contaminants that can derail the most sensitive research efforts.

Looking Ahead with DLPC and Lipid Technology

The past decade has brought more attention to model membranes and synthetic lipid systems. DLPC earns its place as a mainstay not just because of tradition, but because practical, hands-on chemistry supports its consistent performance. As downstream users get more sophisticated — optimizing drug-loaded vesicles, building hybrid nanoparticle-lipid systems — the quality bar moves ever higher. We keep DLPC production at the level where every analysis is public, every change is logged, and technical support is delivered by chemists, not scripts. Supply chain integrity and transparent process control ensure that every shipment fits the needs of demanding, real-world science.

We see sharp differences between commodity-grade chemical trading and the needs of true lipid engineering. Through years of feedback and iterative improvement, our DLPC product line reflects the lessons learned in the field, not just judged on specs sheets or stability studies. That commitment will carry through as technology and application domains keep expanding. For researchers and product developers, working with lipids of known origin, tight analytical oversight, and direct technical support makes DLPC more than a simple building block — it’s a tested, trusted platform for discovery.